Levodopa's awakening effect on patients with Parkinsonism
- PMID: 4398342
- PMCID: PMC1083453
- DOI: 10.1136/jnnp.34.3.209
Levodopa's awakening effect on patients with Parkinsonism
Abstract
The effects of levodopa on tests measuring auditory and visual perception, auditory, and visual short-term memory, verbal learning, and on attention and concentration were studied in 29 patients with Parkinsonism. Thirty-two control subjects matched with the Parkinsonism patients on age, educational level, and verbal IQ were administered the same tests to control for practice effects. Significant improvement occurred for the Parkinsonism patients in verbal learning (an intermediate memory test) and in auditory perception. These improvements were unrelated to changes in anticholinergic medications, increases in alertness or concentration, lessening of depression, or improved motor ability or control. There was no test evidence of levodopa improving visual perception, short-term auditory or visual memory, alertness or concentration. Thus, there is no objective test evidence for levodopa producing a generalized awakening or an alerting effect in Parkinsonism patients who are intellectually alert and well-orientated. Interpretation of the test findings suggests a specific awakening effect, that of improvement in intermediate memory but not in short-term memory. Overall, the Parkinsonism group scored below the control group on all tests, suggesting that cognitive impairment accompanies Parkinson's disease even in patients who are intellectually intact and well oriented.
Similar articles
-
Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.Drugs. 1971;2(4):262-400. doi: 10.2165/00003495-197102040-00002. Drugs. 1971. PMID: 4340597 Review. No abstract available.
-
[Memory changes in Parkinson's disease. Relation with clinical variables].Neurologia. 1992 Feb;7(2):55-60. Neurologia. 1992. PMID: 1610601 Spanish.
-
Psychological studies of longer range L-DOPA therapy in Parkinsonism.J Nerv Ment Dis. 1973 Dec;157(6):452-64. doi: 10.1097/00005053-197312000-00007. J Nerv Ment Dis. 1973. PMID: 4148472 No abstract available.
-
[Influence of attention on an auditory-verbal learning test in schizophrenic patients].Encephale. 2002 Jul-Aug;28(4):291-7. Encephale. 2002. PMID: 12232538 French.
-
Modality effects and the structure of short-term verbal memory.Mem Cognit. 1989 Jul;17(4):398-422. doi: 10.3758/bf03202613. Mem Cognit. 1989. PMID: 2668697 Review.
Cited by
-
Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.Drugs. 1971;2(4):262-400. doi: 10.2165/00003495-197102040-00002. Drugs. 1971. PMID: 4340597 Review. No abstract available.
-
Cognitive concomitants of dopamine system stimulation in parkinsonian patients.J Neurol Neurosurg Psychiatry. 1987 Sep;50(9):1192-6. doi: 10.1136/jnnp.50.9.1192. J Neurol Neurosurg Psychiatry. 1987. PMID: 3668568 Free PMC article.
-
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.Drugs Aging. 1997 May;10(5):367-83. doi: 10.2165/00002512-199710050-00005. Drugs Aging. 1997. PMID: 9143857 Review.
-
Recognition memory in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1984 Nov;47(11):1174-81. doi: 10.1136/jnnp.47.11.1174. J Neurol Neurosurg Psychiatry. 1984. PMID: 6502175 Free PMC article.
-
L-dopa and arousal.J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):416-20. doi: 10.1136/jnnp.37.4.416. J Neurol Neurosurg Psychiatry. 1974. PMID: 4838912 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources